Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12033 | TPP | 0/1 | 3 years, 5 months ago 21 September 2022 16:47:26 UTC | View, Job request 12033 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12032 | TPP | 0/1 | 3 years, 5 months ago 21 September 2022 16:38:25 UTC | View, Job request 12032 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12030 | TPP | 1/2 | 3 years, 5 months ago 21 September 2022 16:07:39 UTC | View, Job request 12030 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11973 | TPP | 1/1 | 3 years, 5 months ago 20 September 2022 09:44:35 UTC | View, Job request 11973 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11961 | TPP | 0/1 | 3 years, 5 months ago 21 September 2022 07:03:41 UTC | View, Job request 11961 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11960 | TPP | 2/4 | 3 years, 5 months ago 19 September 2022 22:50:18 UTC | View, Job request 11960 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11959 | TPP | 2/4 | 3 years, 5 months ago 19 September 2022 22:03:21 UTC | View, Job request 11959 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11958 | TPP | 1/2 | 3 years, 5 months ago 19 September 2022 21:13:07 UTC | View, Job request 11958 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11952 | TPP | 0/1 | 3 years, 5 months ago 19 September 2022 19:44:49 UTC | View, Job request 11952 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11936 | TPP | 0/1 | 3 years, 5 months ago 19 September 2022 09:55:50 UTC | View, Job request 11936 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11935 | TPP | 1/2 | 3 years, 5 months ago 19 September 2022 09:27:10 UTC | View, Job request 11935 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11925 | TPP | 0/1 | 3 years, 5 months ago 18 September 2022 22:20:42 UTC | View, Job request 11925 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11924 | TPP | 1/2 | 3 years, 5 months ago 18 September 2022 21:23:56 UTC | View, Job request 11924 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11921 | TPP | 1/2 | 3 years, 5 months ago 18 September 2022 17:30:12 UTC | View, Job request 11921 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11920 | TPP | 1/2 | 3 years, 5 months ago 18 September 2022 16:17:47 UTC | View, Job request 11920 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11919 | TPP | 1/1 | 3 years, 5 months ago 18 September 2022 15:41:59 UTC | View, Job request 11919 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11918 | TPP | 1/1 | 3 years, 5 months ago 18 September 2022 15:18:07 UTC | View, Job request 11918 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11917 | TPP | 0/1 | 3 years, 5 months ago 18 September 2022 11:04:16 UTC | View, Job request 11917 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11916 | TPP | 1/1 | 3 years, 5 months ago 18 September 2022 10:34:14 UTC | View, Job request 11916 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11915 | TPP | 0/1 | 3 years, 5 months ago 18 September 2022 10:14:17 UTC | View, Job request 11915 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11849 | TPP | 0/1 | 3 years, 5 months ago 17 September 2022 23:33:08 UTC | View, Job request 11849 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 11827 | TPP | 1/1 | 3 years, 5 months ago 15 September 2022 14:19:06 UTC | View, Job request 11827 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 11823 | TPP | 1/1 | 3 years, 5 months ago 15 September 2022 13:45:25 UTC | View, Job request 11823 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11804 | TPP | 1/1 | 3 years, 5 months ago 15 September 2022 09:24:39 UTC | View, Job request 11804 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 11802 | TPP | 0/1 | 3 years, 5 months ago 15 September 2022 09:13:59 UTC | View, Job request 11802 |